All In Biotech

Drug Trial Radar · NCT04869943

Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer

Randomized Crossover Ph3 to Evaluate Efficacy/Safety of Enobosarm Monotherapy vs Active Control for Treatment of AR+/ER+/HER2- MBC With AR Staining Previously Treated w/Nonsteroidal Aromatase Inhibitor, SERD & CDK 4/6 Inhibitor

Last checked: Nov 19, 2026Latest source record: Jan 26, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

52

Actual

Start

Oct 12, 2021

Primary completion

Jan 9, 2024

Study completion Jan 9, 2024

Sponsor

Lead sponsor
Veru Inc.Industry
Sponsor type
Industry
First posted
May 3, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To demonstrate the efficacy of enobosarmin the treatment of androgen receptor positive (AR+) and estrogen receptor positive (ER+) metastatic breast cancer (MBC) as measured by radiographic progression free survival (rPFS).

Conditions

  • Metastatic Breast Cancer

Interventions

  • EnobosarmDrug

    Oral Enobosarm 9mg per day

  • ExemestaneDrug

    Exemestane monotherapy, exemestane plus everolimus, or selective estrogen receptor modulator (SERM)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To demonstrate the efficacy of Enobosarm in the treatment of androgen receptor positive (AR+) and estrogen receptor positive (ER+) metastatic breast cancer (MBC) as measured by radiographic progression free survival (rPFS).Time frame: Day 120

Locations

54 sites in 4 countries. Site status is shown where the registry gives one.

  • Ironwood Cancer and Research Centers

    Chandler, Arizona

  • Banner Health/ Banner MD Anderson Cancer Center

    Gilbert, Arizona

  • The Oncology Insitute of Hope and Innovation

    Glendale, California

  • Marin Cancer Care, Inc.

    Greenbrae, California

  • California Research Institute (CRI)

    Los Angeles, California

  • University of California San Francisco Comprehensive Cancer Center

    San Francisco, California

  • Providence Medical Group

    Santa Rosa, California

  • Rocky Mountain Cancer Centers

    Denver, Colorado

  • Morton Plant Hospital/ BayCare Health System, Inc

    Clearwater, Florida

  • University of Miami- Sylvester Comprehensive Cancer Center

    Miami, Florida

  • Miami Cancer Institute

    Miami, Florida

  • Woodlands Medical Specialists, PA

    Pensacola, Florida

  • Miami Cancer Institute, Plantation MCIP

    Plantation, Florida

  • University Cancer & Blood Center

    Athens, Georgia

  • Blessing Corporate Services

    Quincy, Illinois

  • MBCCOP - LSU Health Sciences Center

    Shreveport, Louisiana

  • Dana-Farber Cancer Institute Breast Oncology

    Boston, Massachusetts

  • Comprehensive Cancer Centers of Nevada

    Las Vegas, Nevada

  • Astera Cancer Care

    East Brunswick, New Jersey

  • Inspira Medical Center Mullica Hill

    Mullica Hill, New Jersey

  • Inspira Medical Center

    Vineland, New Jersey

  • The Lindner Center for Research and Education at the Christ Hospital

    Cincinnati, Ohio

  • Magee-Women's Hospital

    Pittsburgh, Pennsylvania

  • Tidelands Health

    Murrells Inlet, South Carolina

  • Tennessee Cancer Specialists

    Knoxville, Tennessee

  • Baptist Clinical Research Institute

    Nashville, Tennessee

  • Texas Oncology Sammons Cancer Center

    Dallas, Texas

  • Texas Oncology - Tyler

    Tyler, Texas

  • Virginia Cancer Specialists

    Fairfax, Virginia

  • Virginia Oncology Associates

    Norfolk, Virginia

  • Oncology and Hematology Associates of Southwest Virginia, Inc.

    Roanoke, Virginia

  • MultiCare Institute for Research and Innovation

    Puyallup, Washington

  • Cancer Care Northwest

    Spokane, Washington

  • MultiCare Institute for Research and Innovation

    Spokane, Washington

  • Wojewódzka Przychodnia Onkologiczna, Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Łodzi

    Lodz, Poland

  • Instytut Centrum Zdrowia Matki Polki

    Lodz, Poland

  • Centrum Onkologii Ziemi Lubelskiej im. św. Jana z Dukli

    Lublin, Poland

  • Specjalistyczny Szpital Onkologiczny NU-MED

    Maków Mazowiecki, Poland

  • "Oddział Onkologii Klinicznej i Chemioterapii Europejskie Centrum Zdrowia Otwock"

    Otwock, Poland

  • Klinika Nowotworów Piersi i Chirurgii Rekonstrukcyjnej, Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy

    Warsaw, Poland

Showing 40 of 54 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.